Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biomatrix (BXM) Looking Great -- Ignore unavailable to you. Want to Upgrade?

To: AARON DIDICH who wrote (198)	11/16/1997 11:06:00 PM
From: chirodoc	Read Replies (2) \| Respond to of 569

<<<<<<<Your thoughts and questions welcome. you should not have offered--i always have questions: 1. have your buddies heard of anika and their orthovisc? 2. is it only being used for O/A in elders as a single injection? 3. is it every being used as a follow up to scoping? 4. could this replace nsaid's and steriod injections as common O/A knee treatments? thanks!.

To: AARON DIDICH who wrote (198)	11/17/1997 5:56:00 AM
From: James Baker	Read Replies (1) \| Respond to of 569

Aaron, My use of "slanted" was merely to imply that you are not seeing patients in primary care who are getting along but with daily pain and decreased range of motion etc. There must be what 10-30-100 of these for every case that gets to the OR. But absolutely your view from a US location and ortho contacts is extremely valuable. Public knowledge will help push this product. Use after arthroscopy is a new approach as you state. Maybe it will ease the recovery from any arthroscopy eg for trauma in a previously healthy kneee.\??? But I am worried about you. What no investment in BIOX? No BINX?? Better take a look at DITI it is being given away right now and they have a great pipeline of applications - one to detect venous thromboses getting fast track FDA approval right now........next up non small cell lung cancer...then melanoma.......... Jim